Medical Devices Industry Reports Injection Pen Market | Page 2

REPORT DESCRIPTION
Injection Pen Market – Overview
Improving the convenience and ease of administration of parenteral therapeutics has become a common strategy
adopted by biotechnology and pharmaceutical industries and is expected to drive growth of injection pen
market. Key players aim to introduce novel drug delivery system by targeting end-user flexibility such as fewer
handling steps, higher volumes, thinner needles, high viscous formulations, and novel primary containers to
accommodate changing injection pen market trends.
For instance, in 2015, Antares Pharma launched Makena subcutaneous auto injector in collaboration with
AMAG Pharmaceuticals. This collaboration clubs hydroxyprogesterone caproate injection of Antares Pharma
that is used to reduce the risk of preterm birth in women pregnant with a single baby who has a history of
singleton spontaneous preterm birth, with QuickShot auto-injector of AMAG Pharmaceuticals to allow rapid
subcutaneous self-administration of highly viscous drugs in oil such as testosterone or progesterone and
biologics using high spring pressure through a fine gauge needle.
Injection pen has typically been used for frequent self-administration of preserved multi-dose drug formulations
requiring weight-based dosing. It is available in two variants; reusable and disposable injection pens.
© Coherent market Insights. All Rights Reserved